Global Oral Drug Delivery Market Benefits from Expanding Pharmaceutical R&D Investments
Market Overview
The Oral Drug Delivery Market size is expected to reach US$ 162.11 billion by 2031 from US$ 100.30 billion in 2024. The market is anticipated to register a CAGR of 7.1% during 2025–2031. Growing patient preference for oral medications, technological advancements in drug delivery systems, and favorable government initiatives and regulatory support are among the major factors contributing to market growth.
The increasing demand for patient-friendly treatment options is encouraging pharmaceutical companies to invest in advanced oral formulations. Controlled-release technologies, orodispersible tablets, and improved taste-masking solutions are helping address formulation challenges while enhancing medication convenience. Furthermore, opportunities in generic oral drug delivery systems, research collaborations, and oral biologic drug development are expected to support market expansion.
Download Sample PDF: https://www.theinsightpartners.com/sample/TIPRE00004207
Growing Patient Preference for Oral Medications
Increasing patient preference for oral medications over injectable treatments is a significant factor supporting the Oral Drug Delivery Market. Tablets, capsules, and other oral formulations are convenient to administer and generally do not require specialized medical equipment or assistance from healthcare professionals. These benefits make oral medicines suitable for outpatient treatment and home healthcare applications.
The growing focus on patient-centered healthcare is also encouraging pharmaceutical manufacturers to develop easy-to-administer formulations. Improved dosage forms and formulation technologies are helping enhance treatment adherence, particularly among patients requiring long-term medication for chronic diseases.
Technological Advancements in Drug Delivery Systems
Continuous advancements in pharmaceutical formulation technologies are creating new growth opportunities in the oral drug delivery industry. Controlled-release systems, nano-based formulations, and oral thin films are helping improve drug absorption, stability, and therapeutic performance. These technologies can also support more consistent drug release and reduce the frequency of medication administration.
Pharmaceutical companies are increasingly investing in research and development to overcome challenges associated with drug solubility, bioavailability, and gastrointestinal degradation. Such innovations are supporting the development of advanced oral formulations for complex therapeutic applications.
Favorable Government Initiatives and Regulatory Support
Government initiatives and regulatory support are contributing to the development of innovative oral drug delivery solutions. Regulatory frameworks and healthcare policies supporting pharmaceutical research, generic medicine development, and improved access to treatment are encouraging manufacturers to introduce new formulations.
Support for pharmaceutical innovation and the development of affordable medicines can also help expand access to oral therapies. As companies continue investing in research and development, regulatory progress and product approvals are expected to influence future market opportunities.
Advancements in Oral Biologic Drug Delivery
The development of oral delivery technologies for biologic drugs represents an important opportunity for the market. Many biologic medicines are traditionally administered through injections because their molecular structures can make oral delivery challenging. Research into advanced polymers, nanoformulations, and protective delivery technologies is exploring ways to improve the stability and absorption of biologic compounds through oral administration.
Successful advancements in this area could provide patients with more convenient treatment options and create new opportunities for pharmaceutical companies. Continued research and regulatory progress will be important to the development of oral biologic therapies.
Top Players in the Oral Drug Delivery Market
Key companies profiled in The Insight Partners report include:
-
Emisphere Technologies Inc.
-
Merrion Pharmaceuticals Plc
-
Oramed Pharmaceuticals
-
Samyang Corporation
-
Unigene Laboratories Inc.
-
BD
-
Chimerix Inc.
-
Skyepharma
-
Evonik Nutrition & Care GmbH
-
Amcor Limited
Market Segmentation
By Type
-
Controlled Release
-
Orodispersible Tablets and Taste Making
By Geography
-
North America: United States, Canada, and Mexico
-
Europe: United Kingdom, Germany, France, Russia, Italy, and Rest of Europe
-
Asia Pacific: China, India, Japan, Australia, and Rest of Asia Pacific
-
South and Central America: Brazil, Argentina, and Rest of South and Central America
-
Middle East and Africa: South Africa, Saudi Arabia, UAE, and Rest of Middle East and Africa
Future Outlook
The Oral Drug Delivery Market is expected to experience continued growth through 2031, supported by rising demand for convenient medication administration and ongoing improvements in pharmaceutical formulation technologies. Controlled-release systems, orodispersible tablets, and advanced taste-masking technologies are expected to remain important areas of product development.
About Us
The Insight Partners, we provide comprehensive analysis and insights into market trends that empower businesses to make informed decisions. Our reports are designed to equip stakeholders with the necessary information to navigate the complexities of various industries, including healthcare, technology, and finance. We are dedicated to delivering high-quality research that enables our clients to achieve their strategic objectives.
Contact Us:
Contact Person: Ankit Mathur
E-mail: [email protected]
Phone: +1-646-491-9876
Also Available in : Korean German Japanese French Chinese Italian Spanish
- Art
- Causes
- Crafts
- Dance
- Drinks
- Film
- Fitness
- Food
- Games
- Gardening
- Health
- Home
- Literature
- Music
- Networking
- Other
- Party
- Religion
- Shopping
- Sports
- Theater
- Wellness